ENLIGHT Trial: ESG With Fundal Mucosal Ablation
ENLIGHT Trial: ESG With Fundal Mucosal Ablation
Not yet recruiting · NCT07792226 · Registry updated 2026-08-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| ENLIGHT Trial: ESG With Fundal Mucosal Ablation | Body Weight, Digestive System Diseases, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, cardiovascular disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, liver disorder, metabolic disease, nutritional disorder, obesity disorder, overnutrition, type 2 diabetes mellitus, vascular disorder | Not yet recruiting | Not applicable | 2026-08-28 | NCT07792226 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| West Virginia University | 58 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| West Virginia University | Morgantown | United States | 87 |